Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

307
Real-time Quote. Real-time TRADEGATE AG - 05/22 10:01:57 pm
137.4250 EUR   -0.24%
05/21DJFor CVS, Big Bet On Pricey Medicines
05/21DJCVS to Buy Omnicare for $10.4 Billion
05/20 SINOCARE : May Submit Bid to Acquire Diabetes Devices Business from ..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
133.9(c) 137.5(c) 137.25(c) 137.75(c) 137.1(c) Last
1 970 886 2 130 360 1 618 484 1 394 325 1 598 447 Volume
+2.64% +2.69% -0.18% +0.36% -0.47% Change
More quotes
Financials (€)
Sales 2015 47 213 M
EBIT 2015 8 025 M
Net income 2015 4 188 M
Debt 2015 18 785 M
Yield 2015 1,82%
Sales 2016 48 465 M
EBIT 2016 8 569 M
Net income 2016 5 192 M
Debt 2016 15 330 M
Yield 2016 2,02%
PER 2015 26,75
PER 2016 21,47
EV / Sales 2015 2,80x
EV / Sales 2016 2,66x
Capitalization 113 375 M
More Financials
Company
Bayer AG is engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
05/27 | 04:00amShareholder meeting
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
05/23 BAYER : Aktiengesellschaft: Publication according to § 26 paragraph. 1 WpHG wit..
05/21DJFor CVS, Big Bet On Pricey Medicines
05/21DJCVS to Buy Omnicare for $10.4 Billion
05/20 SINOCARE : May Submit Bid to Acquire Diabetes Devices Business from Bayer
05/20 Sinocare bids for Bayer's Contour unit - Bloomberg
05/19 BAYER : May Acquire Sirtex Medical
05/19 BAYER : at a glance: -- New edition of “Names, Figures, Facts” -- Se..
05/18 Dr. Guy Ezekiel Named Brainsway's New President %7E CEO
More news
Sector news : Pharmaceuticals - NEC
05/23 GERMANY'S MERCK EXPECTS DRUG DIVISIO : Euro am Sonntag
05/22DJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca -- Update
05/22 AMGEN : ends work on experimental psoriasis drug
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER AG 
2014The EUR 100 area as entry point
2014The EUR 104 resistance as main obstacle
More Strategies
News from SeekingAlpha
05/20 Aveo Oncology remains optimistic with tivozanib
05/11 Can-Fite cleared to start CF102 Phase 2 trial in Europe for liver cancer
05/11 Regeneron Beats, Raises And Accelerates Its Late-Stage Product Development
05/10 WEEK IN REVIEW : Xinbang Pharma Acquires Chinese Peptide Co. For $323 Million
05/08 FDA clears Bayer antibiotic for the treatment of plague


Comments 
Advertisement
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions